<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Annals of Oncology[TA]</title><link>http://www.unboundmedicine.com/medline/ebm/journal/Annals_of_Oncology</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Chemotherapy for breast cancer during pregnancy: is epirubicin safe?</title><link>http://www.unboundmedicine.com/medline/ebm/record/18765465/full_citation/Chemotherapy_for_breast_cancer_during_pregnancy:_is_epirubicin_safe</link><description>Mir O, Berveiller P, Rouzier R, et al. <br/><span class="title">Chemotherapy for breast cancer during pregnancy: is epirubicin safe? [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2008 Sep 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18765465/full_citation/Chemotherapy_for_breast_cancer_during_pregnancy:_is_epirubicin_safe">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=18765465">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18765465/Chemotherapy_for_breast_cancer_during_pregnancy:_is_epirubicin_safe">Find Related Articles</a> </description></item><item><title>Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18765464/full_citation/Thymidine_phosphorylase_expression_and_benefit_from_capecitabine_in_patients_with_advanced_breast_cancer_</link><description>Andreetta C, Puppin C, Minisini A, et al. <br/><span class="title">Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2008 Sep 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18765464/abstract/Thymidine_phosphorylase_expression_and_benefit_from_capecitabine_in_patients_with_advanced_breast_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18765464/full_citation/Thymidine_phosphorylase_expression_and_benefit_from_capecitabine_in_patients_with_advanced_breast_cancer_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=18765464">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18765464/Thymidine_phosphorylase_expression_and_benefit_from_capecitabine_in_patients_with_advanced_breast_cancer_">Find Related Articles</a> </description></item><item><title>Cancer risks in Crohn disease patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18765463/full_citation/Cancer_risks_in_Crohn_disease_patients_</link><description>Hemminki K, Li X, Sundquist J, et al. <br/><span class="title">Cancer risks in Crohn disease patients. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2008 Sep 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18765463/abstract/Cancer_risks_in_Crohn_disease_patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18765463/full_citation/Cancer_risks_in_Crohn_disease_patients_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=18765463">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18765463/Cancer_risks_in_Crohn_disease_patients_">Find Related Articles</a> </description></item><item><title>The causes of cancer in France.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18765462/full_citation/The_causes_of_cancer_in_France_</link><description>Boffetta P, Tubiana M, Hill C, et al. <br/><span class="title">The causes of cancer in France. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2008 Sep 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18765462/abstract/The_causes_of_cancer_in_France_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18765462/full_citation/The_causes_of_cancer_in_France_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=18765462">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18765462/The_causes_of_cancer_in_France_">Find Related Articles</a> </description></item><item><title>The risk of taking the part by the whole.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18765461/full_citation/The_risk_of_taking_the_part_by_the_whole_</link><description>Castro E, de Álava E <br/><span class="title">The risk of taking the part by the whole. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2008 Sep 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18765461/full_citation/The_risk_of_taking_the_part_by_the_whole_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=18765461">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18765461/The_risk_of_taking_the_part_by_the_whole_">Find Related Articles</a> </description></item><item><title>Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000-2006.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18765460/full_citation/Trends_in_quality_of_end_of_life_care_for_Taiwanese_cancer_patients_who_died_in_2000_2006_</link><description>Tang ST, Wu SC, Hung YN, et al. <br/><span class="title">Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000-2006. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2008 Sep 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18765460/abstract/Trends_in_quality_of_end_of_life_care_for_Taiwanese_cancer_patients_who_died_in_2000_2006_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18765460/full_citation/Trends_in_quality_of_end_of_life_care_for_Taiwanese_cancer_patients_who_died_in_2000_2006_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=18765460">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18765460/Trends_in_quality_of_end_of_life_care_for_Taiwanese_cancer_patients_who_died_in_2000_2006_">Find Related Articles</a> </description></item><item><title>Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18725393/full_citation/Loss_of_enterocyte_mass_is_accompanied_by_diminished_turnover_of_enterocytes_after_myeloablative_therapy_in_haematopoietic_stem_cell_transplant_recipients_</link><description>Derikx JP, Blijlevens NM, Donnelly JP, et al. <br/><span class="title">Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2008 Aug 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18725393/abstract/Loss_of_enterocyte_mass_is_accompanied_by_diminished_turnover_of_enterocytes_after_myeloablative_therapy_in_haematopoietic_stem_cell_transplant_recipients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18725393/full_citation/Loss_of_enterocyte_mass_is_accompanied_by_diminished_turnover_of_enterocytes_after_myeloablative_therapy_in_haematopoietic_stem_cell_transplant_recipients_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=18725393">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18725393/Loss_of_enterocyte_mass_is_accompanied_by_diminished_turnover_of_enterocytes_after_myeloablative_therapy_in_haematopoietic_stem_cell_transplant_recipients_">Find Related Articles</a> </description></item><item><title>Cancer in adolescents and young adults in north Netherlands (1989-2003): increased incidence, stable survival and high incidence of second primary tumours.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18725392/full_citation/Cancer_in_adolescents_and_young_adults_in_north_Netherlands__1989_2003_:_increased_incidence_stable_survival_and_high_incidence_of_second_primary_tumours_</link><description>van Gaal JC, Bastiaannet E, Schaapveld M, et al. <br/><span class="title">Cancer in adolescents and young adults in north Netherlands (1989-2003): increased incidence, stable survival and high incidence of second primary tumours. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2008 Aug 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18725392/abstract/Cancer_in_adolescents_and_young_adults_in_north_Netherlands__1989_2003_:_increased_incidence_stable_survival_and_high_incidence_of_second_primary_tumours_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18725392/full_citation/Cancer_in_adolescents_and_young_adults_in_north_Netherlands__1989_2003_:_increased_incidence_stable_survival_and_high_incidence_of_second_primary_tumours_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=18725392">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18725392/Cancer_in_adolescents_and_young_adults_in_north_Netherlands__1989_2003_:_increased_incidence_stable_survival_and_high_incidence_of_second_primary_tumours_">Find Related Articles</a> </description></item><item><title>Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18725391/full_citation/Estrogens_oral_contraceptives_and_hormonal_replacement_therapy_increase_the_incidence_of_cutaneous_melanoma:_a_population_based_case_control_study_</link><description>Koomen ER, Joosse A, Herings RM, et al. <br/><span class="title">Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2008 Aug 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18725391/abstract/Estrogens_oral_contraceptives_and_hormonal_replacement_therapy_increase_the_incidence_of_cutaneous_melanoma:_a_population_based_case_control_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18725391/full_citation/Estrogens_oral_contraceptives_and_hormonal_replacement_therapy_increase_the_incidence_of_cutaneous_melanoma:_a_population_based_case_control_study_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=18725391">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18725391/Estrogens_oral_contraceptives_and_hormonal_replacement_therapy_increase_the_incidence_of_cutaneous_melanoma:_a_population_based_case_control_study_">Find Related Articles</a> </description></item><item><title>The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18725390/full_citation/The_role_of_secondary_cytoreduction_in_the_management_of_the_first_relapse_in_epithelial_ovarian_cancer_</link><description>Oksefjell H, Sandstad B, Tropé C <br/><span class="title">The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2008 Aug 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18725390/abstract/The_role_of_secondary_cytoreduction_in_the_management_of_the_first_relapse_in_epithelial_ovarian_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18725390/full_citation/The_role_of_secondary_cytoreduction_in_the_management_of_the_first_relapse_in_epithelial_ovarian_cancer_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=18725390">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18725390/The_role_of_secondary_cytoreduction_in_the_management_of_the_first_relapse_in_epithelial_ovarian_cancer_">Find Related Articles</a> </description></item></channel></rss>